Skip to Main Content
Table 2

Summary of type and length of response to TM therapy

No. of patients (Total = 18)Duration in days of copper deficiency (average)
Type of response   
Did not achieve target Cp  
Achieved target Cp 14  
Target Cp <90 days 8/14  
Disease progression  
Stable disease with partial regression of lung lesions 49a 
Target Cp >90 days 6/14  
Stable disease with partial regression of lung lesions 1/6 120a 
Stable disease 4/6 159b, 329a, 351a, 413a (313a
Disease progression at one site, stable elsewhere 1/6 120a 
No. of patients (Total = 18)Duration in days of copper deficiency (average)
Type of response   
Did not achieve target Cp  
Achieved target Cp 14  
Target Cp <90 days 8/14  
Disease progression  
Stable disease with partial regression of lung lesions 49a 
Target Cp >90 days 6/14  
Stable disease with partial regression of lung lesions 1/6 120a 
Stable disease 4/6 159b, 329a, 351a, 413a (313a
Disease progression at one site, stable elsewhere 1/6 120a 
a

On therapy.

b

Patient discontinued therapy.

Close Modal

or Create an Account

Close Modal
Close Modal